๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Beijing
Clinical trial register · China

Clinical Trials in Beijing

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Peking Union Medical College Hospital276 Beijing Tiantan Hospital214 Cancer Institute and Hospital, Chinese Academy of Medical Sciences197 AstraZeneca183 Peking University People's Hospital158
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
5484 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
PCSK9 Inhibitor for Intracranial Atherosclerosis Related Acute Ischemic Stroke
NCT07466251Acute Ischemic Stroke AIS, Intracranial Atherosclerosis ICAS, Atherosclerotic Plaque
Peking Union Medical College Hospital
Phase 4
1,212
Beijing, Meizhou, Cangzhou, Qinhuangdao, Shijiazhuang, Tangshan, Harbin, Zhengzhou
2026-09-01
Not yet open
Effect of Mazdutide on Coronary Plaque in Patients With Coronary Atherosclerosis and Overweight or Obesity
NCT07657676Obesity & Overweight, Coronary Heart Disease
China National Center for Cardiovascular Diseases
Phase 4
116
Beijing
2026-09-01
Not yet open
Endovascular Treatment for Symptomatic Non-acute Carotid Occlusion
NCT07803419Non-acute Carotid Artery Occlusion, Cognitive Impairment
Dapeng Mo
Not applicable
180
Beijing
2026-09-01
Not yet open
Pre-hepatectomy Rehabilitation in Obese MASLD-Complicated Living Liver Donors With Mazdutide (PRIME)
NCT07718126Metabolic Dysfunction-Associated Steatohepatitis, Hepatic Steatosis, Living Liver Donors
West China Hospital
Phase 2/3
60
Hefei, Beijing, Chengdu
2026-09-01
Not yet open
SKB264 Plus KL-A167 in MSI-H/dMMR Advanced Gynecological Malignancies
NCT07738757Recurrent or Metastatic MSI-H/dMMR Gynecological Malignancies
Peking Union Medical College Hospital
Phase 2
80
Jinan, Beijing
2026-09-01
Not yet open
Titration of PS Guided by FI : A Pilot Study
NCT07769307Mechanical Ventilation
Capital Medical University
Not applicable
60
Beijing
2026-09-01
Not yet open
Cognitive Outcomes in BAD-related Stroke
NCT07761182Branch Atheromatous Disease, Cognitive, Deterioration, Clinical
Peking Union Medical College Hospital
Observational
60
Beijing
2026-09-01
Not yet open
Efficacy and Safety of Intravenous Dexamethasone Palmitate Treatments in Acute and Subacute Herpes Zoster Pain
NCT07344246Herpes Zoster Pain
Beijing Tiantan Hospital
Not applicable
954
Beijing
2026-09-01
Recruiting
Long-term Safety of Eplontersen Treated aTTR Patients and in Liver Transplant and Severely Hepatic Impaired Subpopulations
NCT07654855Transthyretin Amyloidosis, Transthyretin Amyloidosis With Cardiomyopathy, Transthyretin Amyloidosis With Polyneuropathy
AstraZeneca
Observational
320
Beijing
2026-09-01
Not yet open
China Treatment Trial for Tumor in Sellar Region With Unruptured Intracranial Aneurysm
NCT07809178Unruptured Intracranial Aneurysms, Pituitary Neuroendocrine Tumor, Craniopharyngioma, Meningioma
Cheng sen
Observational
608
Beijing
2026-09-01
Not yet open
Prospective Study on the Effectiveness and Safety of Bi-polar Pulse-field Tip-catheter Ablation for Atrial Fibrillation in China๏ผˆPOTENTIAL-AF๏ผ‰
NCT07627685Atrial Fibrillation
Beijing Anzhen Hospital
Observational
30,000
Beijing
2026-09-01
Recruiting
The Effects of the Yi Jin Jing on the Muscles and Bones of Adults
NCT07753291Musculoskeletal Health, Healthy Adult Volunteers
Beijing Hospital of Traditional Chinese Medicine
Not applicable
50
Beijing
2026-09-01
Not yet open
A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Weekly Compared to Placebo in Chinese Adults With Overweight or Obesity
NCT07792954Obesity, Overweight
Pfizer
Phase 3
300
Hefei, Beijing, Chongqing, Huizhou, Hengshui, Shijiazhuang, Harbin, Luoyang
2026-09-01
Not yet open
Phase 3 Study of MWN109 Injection in Participants With Overweight or Obesity
NCT07778693Overweight , Obesity
Shanghai Minwei Biotechnology Co., Ltd
Phase 3
760
Beijing
2026-09-01
Not yet open
Wastewater Surveillance for Carbapenem-Resistant Organism Outbreak Prediction in a Chinese Tertiary Hospital
NCT07804433Drug Resistance, Bacterial, Carbapenems, Wastewater
Peking Union Medical College Hospital
Observational
720
Beijing
2026-09-01
Recruiting
Efficacy and Safety of Telitacicept in the Treatment of Refractory Rheumatoid Arthritis
NCT07796516Difficult-to-treat Rheumatoid Arthritis, Rheumatoid Arthritis
Peking University People's Hospital
Phase 2
420
Hefei, Beijing, Chongqing, Quanzhou, Guangzhou, Jiangmen, Shenzhen, Nanning
2026-09-01
Not yet open
Effect of Inspired Oxygen Concentration on Postoperative Atelectasis After VATS Lobectomy
NCT07721558Atelectasis, Postoperative Pulmonary Complications
Peking University People's Hospital
Not applicable
100
Beijing
2026-09-01
Recruiting
High-density Flexible ฮผECoG for Epilepsy Surgery - A Single-Arm ECT
NCT07656857Focal Epilepsy, Intraoperative Monitoring
Beijing Tiantan Hospital
Not applicable
85
Beijing
2026-09-01
Not yet open
Exercise Intervention for Breast Cancer Patients With Sarcopenia
NCT07732101Sarcopenia, Breast Cancer
Capital Medical University
Not applicable
104
Beijing
2026-09-01
Not yet open
TEAS for Sedation During ERCP: A Multicenter Trial With Mechanistic Substudy
NCT07440342Endoscopic Retrograde Cholangiopancreatography, Conscious Sedation Adverse Event, Procedural Pain, Sedation-related Complications
Beijing 302 Hospital
Not applicable
130
Beijing
2026-09-01
Not yet open
IVUS-Guided Sirolimus-Coated Balloon Versus Sirolimus-Eluting Stent for De Novo Large Vessel Lesions in ACS
NCT07796412Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
China National Center for Cardiovascular Diseases
Not applicable
150
Beijing
2026-09-01
Not yet open
A Study of Mezagitamab in Adults With Late Antibody-Mediated Rejection (AMR) After a Kidney Transplant
NCT07613359Antibody-Mediated Rejection (AMR)
Takeda
Phase 2
36
Beijing, Guangdong, Nanning, Wuhan, Xi'an, Jinan, Chengdu, Hangzhou
2026-09-01
Not yet open
Clinical Trials Comparing Trastuzumab Plus Bevacizumab With Bevacizumab as First-line Maintenance Therapy for Epithelial Ovarian Cancer
NCT07779538Ovarian Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3
420
Beijing, Zhejiang, Yunnan
2026-09-01
Not yet open
A Study of ATG-201 in Adult Participants With Autoimmune Diseases
NCT07732309Systemic Lupus Erythematosus, Systemic Sclerosis (SSc), Sjogren's Disease, Autoimmune Diseases
Antengene Biologics Limited
Phase 1
149
Bengbu, Hefei, Beijing, Xiamen, Guangzhou, Luoyang, Zhengzhou, Wuhan
2026-09-01
Not yet open
Clinical Trial of TQA3605 Tablet in Combination With Nucleos(t)Ide Analogues(NAs) Versus NAs Alone for the Treatment of Patients With Chronic Hepatitis B Virus Infection Who Have Undergone Treatment and Exhibit Low Viral Load or Poor Response
NCT07797231Chronic Hepatitis B
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3
930
Hefei, Wuhu, Beijing, Chongqing, Fuzhou, Xiamen, Lanzhou, Wuwei
2026-09
Not yet open
Study on the Mass Balance of [14C] CMS-D002 in Healthy Adult Participants in China
NCT07788482Healthy Volunteers
Shenzhen Kangzhe Biotechnology Co., Ltd.
Phase 1
10
Beijing
2026-09
Not yet open
Context-Guided Personalized iTBS for Depression
NCT07743398Major Depressive Disorder (MDD)
Capital Medical University
Not applicable
60
Beijing
2026-09
Not yet open
A Study of BL-M08D in Patients With Locally Advanced or Metastatic Digestive Tract Tumors and Other Solid Tumors
NCT07780318Gastrointestinal Tumors, Solid Tumors
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1/2
60
Beijing
2026-09
Recruiting
Real World Study of Icotinib in Adjuvant Post Surgical Treatment for Stage IA2 High Risk to IB EGFR Mutant Non Small Cell Lung Cancer
NCT07806604NSCLC (Non-small Cell Lung Cancer)
Betta Pharmaceuticals Co., Ltd.
Observational
2,572
Beijing, Shanghai
2026-09
Not yet open
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of HDM1005 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity Receiving Positive Airway Pressure (PAP) Therapy
NCT07794397Obstructive Sleep Apnea (OSA) and Obesity
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 3
200
Beijing
2026-09
Not yet open
A Study of BL-B01D1 Combination Therapy in Patients With Metastatic Castration-resistant Prostate Cancer
NCT07641855Castration-resistant Prostate Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2/3
180
Beijing, Shanghai
2026-09
Not yet open
Oliceridine Versus Sufentanil Analgesia for Postoperative Patients With Obstructive Sleep Apnea
NCT07753785Obstructive Sleep Apnea, Postoperative Analgesia, Oliceridine, Sufentanil
Peking University First Hospital
Observational
851
Beijing
2026-09
Not yet open
A Clinical Trial of TQF3250 Capsules in Overweight/Obese Trial Participants With Poor Weight Control Through Simple Lifestyle Intervention
NCT07798284Overweight/Obesity
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1
80
Beijing, Guangzhou, Zhengzhou, Wuhan, Xianning, Jinan, Shanghai, Luzhou
2026-09
Not yet open
Study of YKST02 in Adults With Relapsed or Refractory Multiple Myeloma
NCT07695740Relapsed or Refractory Multiple Myeloma (RRMM)
Excyte Biopharma Ltd
Phase 2
64
Beijing
2026-09
Not yet open
A Multicenter Real-World Study Evaluating the Efficacy and Safety of Shugan Jieyu Capsules in the Treatment of Depression
NCT07785284Outpatients or Inpatients With Depression
Peking University
Not applicable
400
Beijing
2026-09
Not yet open
A Study of GFH276 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors and Pancreatic Ductal Adenocarcinoma (PDAC) Harboring RAS Mutation
NCT07678593Advanced Solid Tumors Cancer, Pancreatic Ductal Adenocarcinoma, RAS Mutation
Genfleet Therapeutics (Shanghai) Inc.
Phase 1/2
222
Beijing, Guangzhou, Harbin, Zhengzhou, Wuhan, Shenyang, Xi'an, Jinan
2026-09
Not yet open
Evaluation of 611 in Chinese Children With Moderate to Severe Atopic Dermatitis(AD)
NCT07767253Dermatitis, Atopic
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Phase 3
246
Beijing, Guangzhou, Changsha, Hangzhou
2026-09
Not yet open
Phase Ib Study of Oral R01 Monotherapy in Advanced Solid Tumors
NCT07806500Squamous Cell Lung Cancer, Gastric Cancer, Esophageal Cancer
Beijing Anjianxi Bio-Medical Technology Co., Ltd.
Phase 1
18
Beijing
2026-09
Not yet open
Video-Assisted Thoracoscopic Surgery Combined With Radiofrequency Ablation Versus VATS Alone for Multiple Primary Lung Cancer
NCT07819669Multiple Primary Lung Cancers
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not applicable
160
Taiyuan, Beijing, Shenzhen
2026-09
Not yet open
Phase 3 Study to Evaluate the Efficacy and Safety of Human Growth Hormone Injection (Sinotropin AQ) for the Treatment of Children With Idiopathic Short Stature
NCT07815626Idiopathic Short Stature (ISS)
Zhongshan Sansure Hygene Biomedicine Co., Ltd.
Phase 3
240
Hefei, Beijing, Xiamen, Guangzhou, Tangshan, Wuhan, Changsha, Nanjing
2026-09
Not yet open
Guided Laminectomy With Augmented Duroplasty for Acute Traumatic Spinal Cord Injury
NCT07733401Spinal Cord Injury, Acute Spinal Cord Injury (SCI)
Xuanwu Hospital, Beijing
Not applicable
80
Beijing, Guangzhou, Maoming, Cangzhou, Shijiazhuang, Chifeng, Dezhou, Jinan
2026-09
Not yet open
A Study to Evaluate the Effectiveness and Safety of Restylane Shaype in the Improvement of Jawline Definition
NCT07805512Jawline Definition
Galderma R&D
Not applicable
162
Beijing
2026-09
Not yet open
GLP-1 Agonists for Prevention of Recurrent Hypertriglyceridemic Acute Pancreatitis
NCT07617155Hypertriglyceridemia Induced Acute Pancreatitis, Recurrent Acute Pancreatitis, Pancreatitis Relapsing, Hypertriglyceridemia
Peking Union Medical College Hospital
Phase 4
396
Beijing
2026-09
Recruiting
A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
NCT07680764Locally Advanced Non-Small Cell Lung Cancer (NSCLC), Metastatic Non-Small Cell Lung Cancer (NSCLC)
Bristol-Myers Squibb
Phase 2
160
Beijing, Fuzhou, Wuhan, Nanjing, Shanghai, Chengdu, Hangzhou
2026-08-31
Not yet open
A Phase 3 Study of Efficacy and Safety of AK3280 in Patients With Idiopathic Pulmonary Fibrosis
NCT07719023Idiopathic Pulmonary Fibrosis (IPF)
Shanghai Ark Biopharmaceutical Co., Ltd.
Phase 3
263
Beijing
2026-08-31
Not yet open
Evaluate the Efficacy and Safety of VV913 Capsules in the Treatment of PE
NCT07722780Premature Ejaculation
Vigonvita Life Sciences
Phase 2
500
Beijing
2026-08-31
Recruiting
A Study Comparing BL-M07D1 With DS-8201 in Patients With HR-Positive, HER2-Low Expressing Recurrent/Metastatic Breast Cancer
NCT07678957Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
120
Beijing
2026-08-31
Not yet open
Phase I/II Trial of Human Umbilical Cord Mesenchymal Stromal Cells for UDCA-Refractory Primary Biliary Cholangitis
NCT07795151Primary Biliary Cholangitis
Beijing 302 Hospital
Phase 1/2
68
Beijing
2026-08-31
Recruiting
Phase II Study of Subretinal JWK001 for Neovascular Age-Related Macular Degeneration
NCT07776522Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD
West China Hospital
Phase 2
50
Beijing, Jilin City, Chongqing, Shantou, Zhejiang, Harbin, Zhengzhou, Wuhan
2026-08-31
Not yet open
Clinical Efficacy and Peripheral Ultrasound Mechanism of Trigger Point Bloodletting Therapy for Primary Trigeminal Neuralgia
NCT07750730Trigeminal Neuralgia (TN)
Beijing Hospital of Traditional Chinese Medicine
Not applicable
60
Beijing
2026-08-31
Not yet open
Y-6 Sublingual Tablets for Acute Penetrating Artery Infarction
NCT07721545Perforating Artery Infarction, PAI
Neurodawn Pharmaceutical Co., Ltd.
Phase 2/3
944
Beijing
2026-08-31
Not yet open
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Profiles of TLL-018 in Patients With Moderate-to-Severe Atopic Dermatitis
NCT07784816Atopic Dermatitis (AD)
Hangzhou Highlightll Pharmaceutical Co., Ltd
Phase 2/3
390
Beijing
2026-08-31
Not yet open
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of PTT-121
NCT07768176Healthy Vollunteer
Pyrotech Therapeutics, Inc.
Phase 1
84
Beijing
2026-08-31
Not yet open
A Phase I/II Study of FG-M131 in TRBC1+ Relapsed/Refractory Peripheral T-Cell Lymphoma
NCT07758491PTCL, TRBC1 ADC, CTCL
FutureGen Biopharmaceutical (Beijing) Co., Ltd
Phase 1/2
110
Beijing
2026-08-30
Not yet open
A Study for Postoperative Delirium in Older Patients With Intracranial Tumors
NCT07797660Delirium, Brain Tumor
Beijing Tiantan Hospital
Observational
164
Beijing
2026-08-30
Not yet open
GKL-006Allo Injection in Patients With Advanced Solid Tumors
NCT07704515Solid Tumor Malignancies
Beijing Gene Key Life Technology Co., Ltd
Phase 1
27
Beijing
2026-08-30
Not yet open
A Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Subjects With Type 2 Diabetes
NCT07755150Type 2 Diabetes Mellitus
Chendu DIAO Pharmaceutical Group CO., LTD.
Phase 2
272
Beijing
2026-08-30
Not yet open
Efficacy and Safety of Low-Dose IL-2 in Neuromyelitis Optica Spectrum Disorder
NCT07809724Neuromyelitis Optica Spectrum Disorder (NMOSD)
Peking University People's Hospital
Phase 2
60
Beijing
2026-08-30
Not yet open
Multi-Parameter Temporal Interference Stimulation in Patients With Epilepsy Undergoing SEEG Monitoring
NCT07790224Epilepsy
Beijing Sanbo Brain Hospital
Not applicable
60
Beijing
2026-08-30
Recruiting
Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)
NCT07778316Small Cell Lung Cancer
Amgen
Phase 3
400
Beijing, Shanghai
2026-08-28
Recruiting
A Clinical Study of SHR-A1811 in Combination With Chemotherapy and Bevacizumab Versus Standard Therapy as First-Line Treatment for Advanced Colorectal Cancer
NCT07676162Advanced Colorectal Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3
300
Beijing
2026-08-28
Recruiting
Aneurysm Treatment Using the Heli-FXโ„ข EndoAnchorโ„ข System China Study(ATHENA)
NCT07754318AAA - Abdominal Aortic Aneurysm
Medtronic Cardiovascular
Not applicable
142
Beijing
2026-08-26
Not yet open
A Phase 2b Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After Acute Ischemic Stroke
NCT07645560Ischemic Stroke
Beijing Tiantan Hospital
Phase 2
60
Beijing
2026-08-26
Recruiting
A Clinical Trial of TQB6426 for Injection in Patients With Advanced Solid Tumors
NCT07730190Advanced Malignancies
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Phase 1
145
Hefei, Beijing, Fuzhou, Guangzhou, Harbin, Zhengzhou, Changsha, Shanghai
2026-08-25
Recruiting
GPC3-Targeted PET Imaging of 18F-X12 in Hepatocellular Carcinoma
NCT07795437Hepatocellular Carcinoma (HCC)
Peking University First Hospital
Not applicable
100
Beijing
2026-08-25
Recruiting
A Study of SHR-1501 Combination With BCG Versus Placebo Combined With BCG in Subjects With Papillary-Only NMIBC
NCT07726992Papillary-Only Non-muscle-invasive Bladder Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3
750
Beijing, Guangzhou
2026-08-25
Recruiting
A Study to Assess the Effectiveness and Safety of IPN10200 in Adult Chinese Participants With Moderate to Severe Wrinkle-like Lines Between the Eyebrows
NCT07779252Moderate to Severe Glabellar Lines
Ipsen
Phase 3
160
Guangzhou, Changsha, Nanjing, Wuxi, Jingโ€™an, Chengdu, Hangzhou, Beijing
2026-08-25
Not yet open
A Phase 1 Study of FXR0906 in Healthy Adults With or Without Elevated Triglycerides
NCT07766759Healthy Adult Volunteers
Fosun Pharmaceutical Industrial Development (Shenzhen) Co., Ltd.
Phase 1
24
Beijing
2026-08-25
Not yet open
Phase 1 Clinical Study of GenSci164 Injection
NCT07790783Healthy Adult Trial Participants
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
56
Beijing
2026-08-24
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
AstraZeneca
Phase 3
6,950
Baoding, Beijing, Bozhou, Changchun, Changde, Changsha, Chengdu, Chifeng
2026-08-24
Recruiting
To Assess the Efficacy and Safety of Utilizing Galactose-deficient IgA1 Biomarker Changes to Guide Pathogenic IgA-targeted Therapeutic Strategies
NCT07822100IgA Nephropathy (IgAN), Henoch Schรถnlein Purpura Nephritis
Hong Zhang
Not applicable
374
Beijing
2026-08-24
Recruiting
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
NCT07797335Type 2 Diabetes, Cardiovascular Risk
Novo Nordisk A/S
Phase 3
1,778
Hefei, Beijing, Chongqing, Shenzhen, Cangzhou, Langfang, Shijiazhuang, Kaifeng
2026-08-24
Recruiting
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
NCT07776509Obesity or Overweight, Weight-Related Comorbidity, With/Without Diabetes Mellitus, Type 2
AstraZeneca
Phase 3
500
Beijing, Changchun, Chengdu, Guangzhou, Huzhou, Nanjing, Ningbo
2026-08-24
Not yet open
A Trial of LBL-024 Combined With Platinum-based Chemotherapy for the Treatment of Advanced EP-NEC
NCT07720193Advanced Extrapulmonary Neuroendocrine Carcinoma
Nanjing Leads Biolabs Co.,Ltd
Phase 3
280
Beijing, Fuzhou, Lanzhou, Guangzhou, Nanning, Harbin, Luoyang, Zhengzhou
2026-08-22
Recruiting
A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes Mellitus
NCT07775404Obesity, Overweight
AstraZeneca
Phase 3
351
Baotou, Beijing, Changde, Changsha, Changzhou, Chengdu, Hefei, Huangshi
2026-08-21
Recruiting
Obinutuzumab Beta Combined With Low-dose Glucocorticoid in New-onset ANCA-Associated Glomerulonephritis
NCT07746180ANCA-Associated Glomerulonephritis (AAGN), ANCA-Associated Vasculitis (AAV)
Chinese PLA General Hospital
Phase 2
20
Beijing
2026-08-21
Not yet open
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
NCT07784270Obesity or Overweight, Diabetes Mellitus, Type 2
AstraZeneca
Phase 3
1,500
Beijing, Cangzhou, Changchun, Chengdu, Danyang, Ganzhou, Guangzhou, Huizhou
2026-08-21
Recruiting
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
NCT07753993Chronic Kidney Disease
AstraZeneca
Phase 3
7,000
Baoding, Beijing, Changchun, Changsha, Changzhou, Chengdu, Chenzhou, Chongqing
2026-08-21
Recruiting
Smart Technology Facilitated Patient-centered Care for Patients With Pulmonary Thromboembolism
NCT06382038Venous Thromboembolism, Pulmonary Thromboembolisms, Digital Health
Navy General Hospital, Beijing
Not applicable
2,972
Beijing
2026-08-20
Not yet open
Real-World Efficacy and Safety of Tenapanor Plus Phosphate Binders in Hemodialysis Patients With Hyperphosphatemia
NCT07776119CKD 5D, Hemodialysis, Hyperphosphatemia Undergoing Hemodialysis
Peking University People's Hospital
Observational
200
Beijing
2026-08-20
Not yet open
HCC Risk Prediction Model Based on Multimodal Data in Chronic Hepatitis B
NCT07780357Hepatocellular Carcinoma (HCC)
Beijing Friendship Hospital
Observational
2,000
Beijing
2026-08-20
Not yet open
Acupuncture for Insulin Resistance in Women With Polycystic Ovary Syndrome
NCT07806656Polycystic Ovary Syndrome
Peking University Third Hospital
Not applicable
204
Beijing
2026-08-20
Not yet open
A Phase I Clinical Trial of UX-GIP001 in the Treatment of Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy
NCT07572812Epilepsy
Shanghai UniXell Biotechnology Co., Ltd
Phase 1
12
Beijing, Zhengzhou, Chengdu
2026-08-20
Not yet open
Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma
NCT07700979Gastric / Gastroesophageal Junction Adenocarcinoma
Akeso
Phase 3
900
Beijing, Guangzhou, Shanghai
2026-08-20
Not yet open
Effectiveness of Digital Defocus Vision Training With Low-Concentration Atropine on the Prevention and Control of Myopia in Children: A Clinical Study
NCT07724210Myopia, Prevention and Control
Beijing Tongren Hospital
Not applicable
100
Beijing
2026-08-20
Recruiting
Pemigatinib Plus PD-1 Inhibitor With or Without Chemotherapy in FGFR2 Fusion/Rearrangement-Positive Cholangiocarcinoma
NCT07786766Biliary Tract Cancer (BTC)
Haitao Zhao, MD
Phase 2
154
Beijing
2026-08-20
Recruiting
Study to Assess Adverse Events and How Effective NOA LIFT is Compared to JUVร‰DERM VOLIFT With Lidocaine for the Correction of Nasolabial Folds in Adults
NCT07794878Nasolabial Folds
AbbVie
Phase 3
288
Beijing, Guangzhou, Shenzhen, Nanjing, Xianyang
2026-08-19
Recruiting
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
NCT07784725Obesity or Overweight
AstraZeneca
Phase 3
2,500
Beijing, Cangzhou, Changchun, Changsha, Chengdu, Danyang, Ganzhou, Guiyang
2026-08-19
Recruiting
A Study of SI-B036 in Patients With Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors
NCT07753226Breast Cancer, Solid Tumor
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
39
Beijing
2026-08-18
Recruiting
Observational Study of Natural History of BAG3 Gene Mutation-Associated Dilated Cardiomyopathy in Chinese Adults
NCT07646600Dilated Cardiomyopathy
AstraZeneca
Observational
10
Beijing, Hubei
2026-08-18
Recruiting
A Study of HDM2017 Combination Therapy in Advanced Colorectal Cancer
NCT07805551CRC, Colorectal Cancer
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 1/2
220
Beijing
2026-08-18
Recruiting
Phase II Clinical Study of VC005 Tablets in Subjects With Severe Alopecia Areata
NCT07749716Alopecia Areata
Jiangsu vcare pharmaceutical technology co., LTD
Phase 2
120
Beijing
2026-08-18
Not yet open
A Phase II Study to Evaluate JMKX000197 Injection Versus Cisplatin in the Treatment of Malignant Pleural Effusion
NCT07649369Malignant Pleural Effusions (Mpe)
Shanghai Jeyou Pharmaceutical Co., Ltd.
Phase 2
120
Beijing
2026-08-17
Recruiting
A Phase I/IIa Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics, Immunogenicity, and Preliminary Efficacy of SGT003 in Patients With Advanced Solid Tumors
NCT07811037Advanced Solid Tumor
Beijing Sungen Biomedical Technology Co., Ltd
Phase 1/2
332
Beijing
2026-08-17
Not yet open
Construction and Validation of a Coronary Artery Disease-Specific Large Language Model and Its Evaluation Framework (CorAI)
NCT07766551Coronary Heart Disease (CHD), Artifical Intelligence
China National Center for Cardiovascular Diseases
Observational
640
Hefei, Beijing, Shenzhen
2026-08-17
Recruiting
Evaluate the Concordance Between PET Imaging of [18F]-APN-1607 Injection and Postmortem Brain Tissue Tau Pathology in Individuals With HV and MCI or AD.
NCT07752784Alzheimer's Disease
JYAMS PET Research & Development Limited
Phase 3
12
Beijing
2026-08-15
Not yet open
A Clinical Study of GO321 in Patients With Advanced Solid Tumors
NCT07748117Solid Tumor Malignancies
GeneSail Biotech (Shanghai) Co., Ltd.
Phase 1
21
Beijing
2026-08-15
Not yet open
A Open-Label Phase in Participants With Multiple Myeloma
NCT07764861Multiple Myeloma
Innovent Biologics (Suzhou) Co. Ltd.
Phase 2
120
Beijing
2026-08-15
Not yet open
The Efficacy and Safety of HRS-4029 in Acute Ischemic Stroke Patients
NCT07739160Acute Ischemic Stroke
Beijing Suncadia Pharmaceuticals Co., Ltd
Phase 2
340
Beijing
2026-08-15
Active, closed
Scaffolding in AI-Empowered Cognitive Training Improves Outcomes in Cognitive Impairment
NCT07788209Cognitive Impairment
Xuanwu Hospital, Beijing
Observational
516
Beijing
2026-08-15
Rows per page Showing 101–200 of 5484
Previous 1 2 3 4 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-china/city/beijing?page=2

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.